Michele Follen, M.D., Ph.D., serves Drexel University College of Medicine as director for women’s health research and associate vice dean for research. Dr. Follen also holds an appointment as a professor in the Department of Obstetrics and Gynecology.
Dr. Follen, a prominent gynecologic oncologist and cancer researcher, joins Drexel from the University of Texas M.D. Anderson Cancer Center where she spent 24 years in a number of roles. During her tenure there, she created the Department of Cancer Prevention and served as medical director of the Cancer Screening and Detection Clinic. She also initiated and directed the Biomedical Engineering Center, a consortium of the University of Texas in Austin, The University of Texas Health Science Center in Houston, and M.D. Anderson. In addition, she was responsible for the establishment of the University of Texas’s undergraduate Department of Biomedical Engineering.
Throughout her career, Dr. Follen has received more than $25 million in outside research funding and authored more than 250 peer-reviewed publications. She holds 20 patents for her work in developing advanced screening technologies for the detection of cervical cancer. Dr. Follen is currently the principal investigator of a multi-site Program Project Grant from the National Cancer Institute, entitled “Optical Technologies and Molecular Imaging for Cervical Neoplasia.” In addition, she recently obtained funding from ExxonMobil to establish and manages a screening program of cervical cancer in Nigeria.
Dr. Follen received her undergraduate and medical degrees from the University of Michigan. She also earned a master of science in clinical research design and statistical analysis from the University of Michigan, in addition to a Ph.D. in epidemiologic sciences. She completed an internship in general surgery at the University of Michigan, followed by additional residency training in obstetrics and gynecology at Columbia University Medical Center in New York, and a fellowship in gynecologic oncology at the University of Texas M.D. Anderson Cancer Center. She is a 2002 graduate of the ELAM Program. |